Date lodged: 9 December 2016
To ask the Scottish Government what assessment it has made of the cost benefits of using continuous glucose monitoring, and how much it estimates this technology saves the NHS by preventing, for example, eye disease, amputations and other health problems that can result from diabetes.
Answered by: Aileen Campbell 22 December 2016
Diabetes accounts for around 10% of the health budget and it is estimated that 80% of these costs are for treating complications associated with diabetes, such as diabetic retinopathy, foot ulcers (which can lead to amputation) and renal failure. Attaining good glycaemic control significantly reduces the risk of developing complications.
The Scottish Diabetes Group’s national approach to CGM has been developed taking account of clinical evidence and all the costs associated with the treatment and management of diabetes. It is estimated that for those who would clinically benefit from CGM, the technology can support a reduction in cost to NHS Scotland of around £3,000 per person in relation to short term complications and will contribute towards reducing the costs in relation to longer term complications.